scispace - formally typeset
Open AccessJournal ArticleDOI

Chemotaxis in cancer

TLDR
This Review summarizes how chemotaxis directs the different behaviours of tumour cells and stromal cells in vivo, how molecular pathways regulateChemotaxis in tumours and how chemtaxis choreographs cell behaviour to shape the tumour microenvironment and to determine metastatic spread.
Abstract
Chemotaxis of tumour cells and stromal cells in the surrounding microenvironment is an essential component of tumour dissemination during progression and metastasis. This Review summarizes how chemotaxis directs the different behaviours of tumour cells and stromal cells in vivo, how molecular pathways regulate chemotaxis in tumour cells and how chemotaxis choreographs cell behaviour to shape the tumour microenvironment and to determine metastatic spread. The central importance of chemotaxis in cancer progression is highlighted by discussion of the use of chemotaxis as a prognostic marker, a treatment end point and a target of therapeutic intervention.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Polymorphism of FGD4 and myelosuppression in patients with esophageal squamous cell carcinoma.

TL;DR: In this article, the minor allele of FGD4 rs1239829 was related to grade 3-4 leukopenia in patients with esophageal squamous cell carcinoma treated with taxane/cisplatin, with unclear biological mechanism.
Journal ArticleDOI

Diffusion‐induced anisotropic cancer invasion: a novel experimental method based on tumour spheroids

TL;DR: An innovative methodology for the quantitative investigation of chemotaxis in vitro by live imaging of morphology of cell spheroids, in 3D collagen gel, is presented here and NIH/3T3 sp Heroids are characterized by a limited tendency of cells to invade the surrounding tissue, unlike PANC-1 and HT-1080 that show relatively stronger response to gradients.
Posted ContentDOI

Chemotaxis model for human breast cancer cells based on signal-to-noise ratio

Seongjin Lim, +2 more
- 30 Mar 2018 - 
TL;DR: The results demonstrate that even under the same EGF concentration gradients, breast cancer cells can reveal distinct chemotaxis patterns at different absolute concentrations and suggest that EGF receptor-targeted therapy may stimulate metastasis of breast cancer at a particular condition, which should be considered in anticancer drug design.
Posted ContentDOI

Plasticity of cell migration resulting from mechanochemical coupling

TL;DR: A simple two component biochemical reaction-diffusion model based on relaxation oscillators is presented and the importance of coupling signaling events to cell mechanics and morphology is indicated and may be applicable in a wide variety of cell motility systems.
References
More filters
Journal ArticleDOI

Epithelial-Mesenchymal Transitions in Development and Disease

TL;DR: The mesenchymal state is associated with the capacity of cells to migrate to distant organs and maintain stemness, allowing their subsequent differentiation into multiple cell types during development and the initiation of metastasis.
Journal ArticleDOI

Myeloid-derived suppressor cells as regulators of the immune system.

TL;DR: The origin, mechanisms of expansion and suppressive functions of MDSCs, as well as the potential to target these cells for therapeutic benefit are discussed.
Journal ArticleDOI

Involvement of chemokine receptors in breast cancer metastasis.

TL;DR: It is reported that the chemokine receptors CXCR4 and CCR7 are highly expressed in human breast cancer cells, malignant breast tumours and metastases and their respective ligands CXCL12/SDF-1α and CCL21/6Ckine exhibit peak levels of expression in organs representing the first destinations of breast cancer metastasis.
Related Papers (5)
Trending Questions (2)
What part of chemotaxis in cancer has not been studied yet?

The text does not provide information about any specific part of chemotaxis in cancer that has not been studied yet.

What part of chemotaxis in breast cancer has not been studied yet?

The specific part of chemotaxis in breast cancer that has not been studied yet is not mentioned in the provided information.